TCMBANKIN021487 |
physalien |
[(1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(4R)-4-hexadecanoyloxy-2,6,6-trimethyl-cyclohexen-1-yl]-3,7,12,16-tetramethyl-octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethyl-cyclohex-3-en-1-yl] hexadecanoate; CAS-144-67-2; CHEMBL2359253; 144-67-2; DSSTox_GSID_48707; Ambap144-67-2; CHEBI:8183; MFCD00198033; DSSTox_RID_82903; (3R,3R')-beta,beta-Carotene-3,3'-diyl dipalmitate; Zeaxanthin dipalmitate; [(1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(4R)-4-hexadec; Tox21_113106; UNII-570944I2YB; 570944I2YB; EINECS 205-635-9; beta,beta-Carotene-3,3'-diol, dihexadecanoate, (3R,3'R)-; C08609; DSSTox_CID_28633; SCHEMBL21519; XACHQDDXHDTRLX-XLVVAOPESA-N; [(1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(4R)-4-hexadecanoyloxy-2,6,6-trimethylcyclohexen-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethylcyclohex-3-en-1-yl] hexadecanoate; AC1NQY9X; NCGC00182606-01; Zeaxanthin-di-palmitate; DTXSID6048707; Physalien |
C72H116O4 |
1045.7 g/mol |
CCCCCCCCCCCCCCCC(=O)OC1CC(=C(C(C1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(CC(CC2(C)C)OC(=O)CCCCCCCCCCCCCCC)C)C)C)C |